DB17946InvestigationalProtein Based Therapies
RTL-1000 is a recombinant T-Cell receptor ligand being investigated for the treatment of multiple sclerosis.
- Mechanism
- Curator reviewed
Pharmacologically active on T cell receptor beta constant 1, T-cell surface glycoprotein CD3, and HLA class II histocompatibility antigen gamma chain
- Also known as
- Recombinant t-cell receptor ligand rtl-1000 · Rtl-1000 (recombinant t-cell receptor ligand)
- Code names
- RTL-1000 · VG1000
Resolves to
Compound
Targets
What you can answer from here — as of July 08, 2026
Which drugs share a target with RTL-1000, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account